Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2002; 40:1523-1530
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuchida, A.
Right arrow Articles by Shimamoto, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuchida, A.
Right arrow Articles by Shimamoto, K.

Infarct size limitation by nicorandil

Roles of mitochondrial KATP channels, sarcolemmal KATP channels, and protein kinase C

Akihito Tsuchida, MD, PhD*, Tetsuji Miura, MD, PhD, FACC*,*, Masaya Tanno, MD*, Jun Sakamoto, MD, PhD*, Takayuki Miki, MD, PhD*, Atsushi Kuno, MD*, Tomoaki Matsumoto, MD*, Yoshito Ohnuma, MD*, Yoshihiko Ichikawa, MD* and Kazuaki Shimamoto, MD, PhD*

a Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan



View larger version (18K):

[in a new window]
 
Figure 1 Time course of the activation recovery interval (ARI) before and during ischemia. (A) ARIs in control (open circles), nicorandil (solid circles), 5-hydroxydecanoate (5-HD) (open triangles), and 5-HD + nicorandil (solid triangles) groups. (B) ARIs in HMR1098 (open squares) and HMR1098 + nicorandil (solid squares) groups. Open and solid circles are the same as those in A. *p < 0.05 vs. control; #p < 0.05 vs. nicorandil. Base = baseline; Tx = drug treatment.

 


View larger version (43K):

[in a new window]
 
Figure 2 Effects of calphostin C on translocations of protein kinase C (PKC)-{varepsilon} by ischemic preconditioning (PC). The PKC-{varepsilon} levels in the cytosol and particulate fraction are expressed as percentages of the total. Ischemic preconditioning significantly reduced PKC-{varepsilon} in the cycotol and increased PKC in the particulate fraction, indicating translocation of PKC-{varepsilon} from the cytosol to the particulate fraction. In the hearts pretreated with calphostin C (200 nM), translocation of PKC-{varepsilon} was not detected. Open bar = cytosol; hatched bar = particulate. *p < 0.05 vs. baseline. n = 4 in each treatment group.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement